½ÃÀ庸°í¼­
»óǰÄÚµå
1421740

ÀÇ·á¿ë ½Äǰ ½ÃÀå, Á¡À¯À², ±Ô¸ð, µ¿Çâ, »ê¾÷ ºÐ¼® º¸°í¼­ : Á¦Ç°º°, Åõ¿© °æ·Îº°, ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2023-2032³â)

Medical Foods Market Share, Size, Trends, Industry Analysis Report, By Product (Pills, Powder, Liquid, Others); By Route of Administration (Oral, Enteral); By Application; By Region; Segment Forecast, 2023 - 2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Polaris Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 118 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Polaris Market ResearchÀÇ ÃֽŠÁ¶»ç¿¡ µû¸£¸é, ¼¼°è ÀÇ·á¿ë ½Äǰ ½ÃÀå ±Ô¸ð´Â 2032³â±îÁö 376¾ï 5,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ º¸°í¼­´Â ÇöÀç ½ÃÀå ¿ªÇп¡ ´ëÇÑ ÀÚ¼¼ÇÑ ÅëÂû·Â°ú ¹Ì·¡ ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

ÀÇ·á¿ë ½Äǰ ½ÃÀåÀº ±¤¹üÀ§ÇÑ ÇコÄÉ¾î ¹× ¿µ¾ç »ê¾÷¿¡¼­ ºü¸£°Ô ¼ºÀåÇϰí ÀÖ´Â ºÐ¾ßÀÔ´Ï´Ù. ÀÇ·á¿ë ½ÄǰÀº ÀÏ¹Ý ½ÄǰÀ̳ª °Ç°­º¸Á¶½Äǰ°ú ´Þ¸® ƯÁ¤ ÁúȯÀ̳ª ½Ä´Ü ¿ä°ÇÀ» ÃæÁ·½Ã۱â À§ÇØ Æ¯º°È÷ ó¹æµÈ ½ÄǰÀÔ´Ï´Ù. ÀÇ·á Àü¹®°¡µéÀº ÀϹÝÀûÀ¸·Î ´ë»ç ÀÌ»ó, ¿µ¾ç °áÇÌ ¹× ±âŸ Àü¹®½ÄÀÌ ¿ä¹ýÀÌ µµ¿òÀÌ µÇ´Â Áúº´À» °ü¸®Çϰųª Ä¡·áÇϱâ À§ÇØ ÀÌ·¯ÇÑ Á¦Ç°À» ó¹æÇÕ´Ï´Ù.

¼¼°è ÀÇ·á¿ë ½Äǰ ½ÃÀåÀº ¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡, °í·ÉÈ­ Àα¸ Áõ°¡, °Ç°­ °ü¸®¿¡¼­ ¿µ¾çÀÇ Á߿伺¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡·Î ÀÎÇØ ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ÀÌ ½ÃÀå¿¡´Â ¼ÒÈ­±â Áúȯ ȯÀÚ¸¦ À§ÇÑ °æÀå ¿µ¾çÁ¦ºÎÅÍ ´ë»ç Àå¾Ö ȯÀÚ¸¦ À§ÇÑ ¾Æ¹Ì³ë»ê ±â¹Ý Á¦Ç°±îÁö ´Ù¾çÇÑ Á¦Ç°ÀÌ Æ÷ÇԵǾî ÀÖ¾î ´Ù¾çÇÏ°í ¿ªµ¿ÀûÀÎ »ê¾÷À¸·Î ¼ºÀåÇϰí ÀÖ½À´Ï´Ù.

ÀÇ·á¿ë ½Äǰ ºÐ¾ß¿¡´Â Á¦¾àȸ»ç, À½·á ¹× ½Äǰ Á¦Á¶¾÷ü, ÀÇ·á¿ë ½Äǰ Àü¹®¾÷üµéÀÌ Âü¿©Çϰí ÀÖ½À´Ï´Ù. ÀÇ·á¿ë ½Äǰ¿¡ ´ëÇÑ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©´Â ±¹°¡¸¶´Ù ´Ù¸£¸ç, Á¤ÀÇ¿Í ¿ä±¸»çÇ×µµ ´Ù¸¨´Ï´Ù. ÀÌ´Â ¾î·Á¿î °úÁ¦ÀÌÁö¸¸ µ¿½Ã¿¡ ½ÃÀå ¼ºÀåÀÇ ±âȸÀ̱⵵ ÇÕ´Ï´Ù. ¸ÂÃãÇü ¿µ¾ç°ú Ç¥ÀûÈ­µÈ ½Ä´Ü °³ÀÔ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ÀÇ·á¿ë ½Äǰ ½ÃÀåÀº Áö¼ÓÀûÀÎ ¼ºÀåÀ» ÀÌ·ê °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿µ¾çÀ» ÅëÇÑ °Ç°­ ÁõÁøÀ» ¿øÇϴ ȯÀÚ¿Í ¼ÒºñÀÚÀÇ ´Ù¾çÇÑ ¿ä±¸¸¦ ÃæÁ·½Ãų ¼ö ÀÖ´Â Çõ½ÅÀûÀÎ Á¦Ç°°ú ¼Ö·ç¼ÇÀÌ µîÀåÇÒ °ÍÀÔ´Ï´Ù. ½ÃÀåÀÇ ±ËÀûÀº ÀÇÇÐ ¿¬±¸ÀÇ ¹ßÀü, ÀÇ·á Á¤Ã¥ÀÇ º¯È­, ¼ÒºñÀÚÀÇ ½Ä½À°ü º¯È­¿¡ ¿µÇâÀ» ¹Þ±â ¶§¹®¿¡ ±¤¹üÀ§ÇÑ ÀÇ·á ¹× ¿µ¾ç »ê¾÷¿¡¼­ Áö¼ÓÀûÀÎ °ü½É°ú ÅõÀÚ°¡ ÇÊ¿äÇÑ ºÐ¾ß°¡ µÉ °ÍÀÔ´Ï´Ù.

ÀÇ·á¿ë ½Äǰ »ê¾÷Àº °Ç°­ °ü¸® ¿ä±¸ »çÇ×°ú °í°´ ¼±È£µµÀÇ º¯È­¿¡ µû¶ó ÁøÈ­Çϰí ÀÖ½À´Ï´Ù. °³ÀÎÀÇ À¯ÀüÀû, ´ë»çÀû ÇÁ·ÎÆÄÀÏ¿¡ ¸Â´Â ¸ÂÃãÇü ÀÇ·á¿ë ½ÄǰÀÌ °³¹ßµÇ¸é¼­ °³ÀÎ ¸ÂÃãÇü ¿µ¾çÇÐÀÌ °¢±¤¹Þ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¼ÒºñÀÚµéÀÌ Ã·°¡¹°À̳ª ¾Ë·¹¸£°ÕÀÌ ÀûÀº Á¦Ç°À» ãÀ¸¸é¼­ õ¿¬ Àç·á¿Í Ŭ¸° ¶óº§ÀÌ ºÎÂøµÈ Àç·á¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. µðÁöÅÐ Çコ ¹× ¿ø°Ý ÀÇ·áµµ ÀÇ·á¿ë ½ÄǰÀÇ À¯Åë°ú ó¹æ¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖÀ¸¸ç, ȯÀÚµéÀÌ ÀÇ·á¿ë ½ÄǰÀ» ´õ ½±°Ô Á¢ÇÒ ¼ö ÀÖµµ·Ï µ½°í ÀÖ½À´Ï´Ù.

ÀÇ·á¿ë ½Äǰ ½ÃÀå º¸°í¼­ - ÇÏÀ̶óÀÌÆ®

2022³â ½ÃÀåÀº ºÐ¸» ºÎ¹®ÀÌ Áö¹èÀûÀ̾ú´Âµ¥, ÀÌ´Â ±¤¹üÀ§ÇÑ °¡¿ë¼º, ÆíÀǼº, ´Ù¾çÇÑ ¿¬·ÉÃþ°ú ȯÀÚÀÇ ¿ä±¸¸¦ ÃæÁ·½Ã۱â À§ÇÑ ¸ÂÃãÈ­ µîÀÌ ¿øµ¿·ÂÀÌ µÇ¾ú½À´Ï´Ù.

¾×ü ºÎ¹®Àº ƯÈ÷ ¾î¸°ÀÌ¿Í ³ëÀÎ Àα¸ÀÇ Ã¤Åà Áõ°¡¿¡ ÈûÀÔ¾î ±Þ¼ºÀåÇÒ Áغñ°¡ µÇ¾î ÀÖ½À´Ï´Ù.

ºÐ¸», Á¤Á¦, ³óÃà Á¦Ç° µî ´Ù¾çÇÑ ÇüÅÂÀÇ ÀÇ·á¿ë ½ÄǰÀº ¿©ÀüÈ÷ °æ±¸ Åõ¿©°¡ ÀϹÝÀûÀ̸ç, ¼±ÅÃÀÇ ÆøÀÌ ³Ð¾îÁö¸é¼­ °æ±¸ ºÎ¹®ÀÌ °¡Àå ³ôÀº ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇÏ¸ç ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.

ºÏ¹Ì°¡ ½ÃÀåÀ» ÁÖµµÇÑ °ÍÀº ¼¼°è ´ë±â¾÷ÀÇ Á¸Àç¿Í ´õºÒ¾î ¾÷°è ±â¾÷µéÀÇ Àμö, ÇÕº´, Á¦Ç° Ãâ½Ã µî Àü·«Àû ÀÌ´Ï¼ÅÆ¼ºê°¡ ¼º°øÇ߱⠶§¹®ÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå ¼¼°èÀÇ ÀÇ·á¿ë ½Äǰ ½ÃÀå ÀλçÀÌÆ®

  • ÀÇ·á¿ë ½Äǰ ½ÃÀå - ¿ëµµ ÇöȲ
  • ÀÇ·á¿ë ½Äǰ ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀΰú ±âȸ
    • ¼ºÀå ¾ïÁ¦¿äÀΰú °úÁ¦
  • PESTEL ºÐ¼®
  • ÀÇ·á¿ë ½Äǰ ½ÃÀå ÀÀ¿ë µ¿Çâ
  • ¹ë·ùüÀÎ ºÐ¼®
  • COVID-19ÀÇ ¿µÇ⠺м®

Á¦5Àå ¼¼°èÀÇ ÀÇ·á¿ë ½Äǰ ½ÃÀå, Á¦Ç°º°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­·Ð
  • ȯ¾à
  • ºÐ¸»
  • ¾×ü
  • ±âŸ

Á¦6Àå ¼¼°èÀÇ ÀÇ·á¿ë ½Äǰ ½ÃÀå, Åõ¿© °æ·Îº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­·Ð
  • °æ±¸
  • °æÀå

Á¦7Àå ¼¼°èÀÇ ÀÇ·á¿ë ½Äǰ ½ÃÀå, ¿ëµµº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­·Ð
  • ¸¸¼º ½ÅÀ庴
  • °æµµ °£¼º³úÁõ
  • ´ç´¢º´¼º ½Å°æº´Áõ
  • ¿ì¿ïÁõ
  • ¿µ¾ç ºÎÁ·
  • È­Çпä¹ý¿¡ µû¸¥ ¼³»ç
  • ¾ËÃ÷ÇÏÀ̸Ӻ´
  • º´¿øÃ¼ °ü·Ã °¨¿°Áõ
  • ADHD
  • â»ó Ä¡À¯
  • ¸¸¼º ¼³»ç
  • ÆÄŲ½¼º´
  • ÁßÁõ ´Ü¹éÁú ¾Ë·¹¸£±â
  • ÅëÁõ °ü¸®
  • ±âŸ ¾Ï °ü·Ã Ä¡·á
  • Èñ±Íº´
  • º¯ºñ ÇØ¼Ò
  • °£Áú
  • ÇÁ·ÎÅ×ÀÎ ºÎ½ºÅÍ
  • ¿¬ÇÏÀå¾Ö
  • ±âŸ

Á¦8Àå ¼¼°èÀÇ ÀÇ·á¿ë ½Äǰ ½ÃÀå, Áö¿ªº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­·Ð
    • ÀÇ·á¿ë ½Äǰ ½ÃÀå Æò°¡, Áö¿ªº°, 2019-2032³â
  • ÀÇ·á¿ë ½Äǰ ½ÃÀå - ºÏ¹Ì
    • ºÏ¹Ì : ÀÇ·á¿ë ½Äǰ ½ÃÀå, Á¦Ç°º°, 2019-2032³â
    • ºÏ¹Ì : ÀÇ·á¿ë ½Äǰ ½ÃÀå, ¿ëµµº°, 2019-2032³â
    • ºÏ¹Ì : ÀÇ·á¿ë ½Äǰ ½ÃÀå, Åõ¿© °æ·Îº°, 2019-2032³â
    • ÀÇ·á¿ë ½Äǰ ½ÃÀå - ¹Ì±¹
    • ÀÇ·á¿ë ½Äǰ ½ÃÀå - ij³ª´Ù
  • ÀÇ·á¿ë ½Äǰ ½ÃÀå - À¯·´
    • À¯·´ : ÀÇ·á¿ë ½Äǰ ½ÃÀå, Á¦Ç°º°, 2019-2032³â
    • À¯·´ : ÀÇ·á¿ë ½Äǰ ½ÃÀå, ¿ëµµº°, 2019-2032³â
    • À¯·´ : ÀÇ·á¿ë ½Äǰ ½ÃÀå, Åõ¿© °æ·Îº°, 2019-2032
    • ÀÇ·á¿ë ½Äǰ ½ÃÀå - ¿µ±¹
    • ÀÇ·á¿ë ½Äǰ ½ÃÀå - ÇÁ¶û½º
    • ÀÇ·á¿ë ½Äǰ ½ÃÀå - µ¶ÀÏ
    • ÀÇ·á¿ë ½Äǰ ½ÃÀå - ÀÌÅ»¸®¾Æ
    • ÀÇ·á¿ë ½Äǰ ½ÃÀå - ½ºÆäÀÎ
    • ÀÇ·á¿ë ½Äǰ ½ÃÀå - ³×´ú¶õµå
    • ÀÇ·á¿ë ½Äǰ ½ÃÀå - ·¯½Ã¾Æ
  • ÀÇ·á¿ë ½Äǰ ½ÃÀå - ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ÀÇ·á¿ë ½Äǰ ½ÃÀå, Á¦Ç°º°, 2019-2032³â
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ÀÇ·á¿ë ½Äǰ ½ÃÀå, ¿ëµµº°, 2019-2032³â
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ÀÇ·á¿ë ½Äǰ ½ÃÀå, Åõ¿© °æ·Îº°, 2019-2032³â
    • ÀÇ·á¿ë ½Äǰ ½ÃÀå - Áß±¹
    • ÀÇ·á¿ë ½Äǰ ½ÃÀå - Àεµ
    • ÀÇ·á¿ë ½Äǰ ½ÃÀå - ¸»·¹À̽þÆ
    • ÀÇ·á¿ë ½Äǰ ½ÃÀå - ÀϺ»
    • ÀÇ·á¿ë ½Äǰ ½ÃÀå - Àεµ³×½Ã¾Æ
    • ÀÇ·á¿ë ½Äǰ ½ÃÀå - Çѱ¹
  • ÀÇ·á¿ë ½Äǰ ½ÃÀå - Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ÀÇ·á¿ë ½Äǰ ½ÃÀå, Á¦Ç°º°, 2019-2032³â
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ÀÇ·á¿ë ½Äǰ ½ÃÀå, ¿ëµµº°, 2019-2032
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ÀÇ·á¿ë ½Äǰ ½ÃÀå, Åõ¿© °æ·Îº°, 2019-2032
    • ÀÇ·á¿ë ½Äǰ ½ÃÀå - »ç¿ìµð¾Æ¶óºñ¾Æ
    • ÀÇ·á¿ë ½Äǰ ½ÃÀå - ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • ÀÇ·á¿ë ½Äǰ ½ÃÀå - À̽º¶ó¿¤
    • ÀÇ·á¿ë ½Äǰ ½ÃÀå - ³²¾ÆÇÁ¸®Ä«
  • ÀÇ·á¿ë ½Äǰ ½ÃÀå - ¶óƾ¾Æ¸Þ¸®Ä«
    • ¶óƾ¾Æ¸Þ¸®Ä« : ÀÇ·á¿ë ½Äǰ ½ÃÀå, Á¦Ç°º°, 2019-2032³â
    • ¶óƾ¾Æ¸Þ¸®Ä« : ÀÇ·á¿ë ½Äǰ ½ÃÀå, ¿ëµµº°, 2019-2032
    • ¶óƾ¾Æ¸Þ¸®Ä« : ÀÇ·á¿ë ½Äǰ ½ÃÀå, Åõ¿© °æ·Îº°, 2019-2032³â
    • ÀÇ·á¿ë ½Äǰ ½ÃÀå - ¸ß½ÃÄÚ
    • ÀÇ·á¿ë ½Äǰ ½ÃÀå - ºê¶óÁú
    • ÀÇ·á¿ë ½Äǰ ½ÃÀå - ¾Æ¸£ÇîÆ¼³ª

Á¦9Àå °æÀï ±¸µµ

  • È®Àå ¹× Àμö ºÐ¼®
    • È®´ë
    • Àμö
  • Á¦ÈÞ/Çù¾÷/ÇÕÀÇ/°ø°³

Á¦10Àå ±â¾÷ °³¿ä

  • Abbott
  • Danone
  • Fresenius Kabi
  • Friso
  • Mead Johnson & Company, LLC
  • Medtrition, Inc.
  • Morinaga Milk Industry
  • Nestle S.A.
  • Primus Pharmaceuticals, Inc.
  • Targeted Medical Pharma, Inc.
LSH 24.02.19

The global medical foods market size is expected to reach USD 37.65 billion by 2032, according to a new study by Polaris Market Research. The report "Medical Foods Market Share, Size, Trends, Industry Analysis Report, By Product (Pills, Powder, Liquid, Others); By Route of Administration (Oral, Enteral); By Application; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The market for medical foods is a fast-growing segment within the broader healthcare and nutrition industry. Medical foods are different from conventional foods and dietary supplements because they are specially formulated to address specific medical conditions and dietary requirements. Healthcare professionals commonly prescribe these products to manage or treat conditions such as metabolic disorders, nutritional deficiencies, and other medical conditions where a specialized diet can be beneficial.

The global market for medical foods is expanding due to the increasing prevalence of chronic diseases, a growing aging population, and heightened awareness of the importance of nutrition in managing health. This market encompasses a wide range of products, from enteral nutrition formulas for patients with digestive disorders to amino acid-based products for individuals with metabolic disorders, making it a diverse and dynamic industry.

The medical foods sector involves pharmaceutical companies, food and beverage manufacturers, and specialized medical food companies. The regulatory framework for medical foods varies from one country to another, with different definitions and requirements. This can be challenging but also presents opportunities for market growth. As the demand for personalized nutrition and targeted dietary interventions increases, the medical foods market is expected to see sustained growth. Innovative products and solutions will emerge to meet the diverse needs of patients and consumers looking to improve their health through nutrition. The market's trajectory is influenced by medical research advances, changes in healthcare policies, and shifting dietary preferences of consumers, making it a field of continuous interest and investment in the broader healthcare and nutrition industry.

The medical foods industry is evolving in response to changing healthcare requirements and customer preferences. Personalized nutrition is gaining traction as customized medical foods are being developed to match individual genetic and metabolic profiles. Additionally, there is a growing emphasis on natural and clean-label ingredients, as consumers demand products with fewer additives and allergens. Digital health and telemedicine are also playing a crucial role in distributing and prescribing medical foods, making it simpler for patients to obtain them.

Medical Foods Market Report Highlights

The powder segment dominated the market in 2022, driven by its extensive availability, convenience, and customization to cater to various age groups and patient needs.

The liquid segment is poised for rapid growth, driven by increased adoption, particularly among pediatric and geriatric populations.

The oral segment dominated the market with the highest revenue share, as oral administration remains the prevalent and expanding choice for medical food products in various formats, including powders, pills, and pre-thickened products.

North America led the market due to the presence of major global players, along with strategic initiatives like acquisitions, mergers, and product launches by industry players.

The global key market players include: Abbott, Danone, Fresenius Kabi, Friso, Mead Johnson & Company, LLC, Medtrition, Inc., Morinaga Milk Industry, Nestle S.A., Primus Pharmaceuticals, Inc., Targeted Medical Pharma, Inc.

Polaris Market Research has segmented the Medical Foods market report based on product, route of administration, application, and region:

Medical Foods, Product Outlook (Revenue - USD Billion, 2019 - 2032)

  • Pills
  • Powder
  • Liquid
  • Others

Medical Foods, Route of Administration Outlook (Revenue - USD Billion, 2019 - 2032)

  • Oral
  • Enteral

Medical Foods, Application Outlook (Revenue - USD Billion, 2019 - 2032)

  • Chronic Kidney Disease
  • Minimal Hepatic Encephalopathy
  • Diabetic Neuropathy
  • Depression
  • Nutritional Deficiency
  • Chemotherapy Induced Diarrhoea
  • Alzheimer's Disease
  • Pathogen Related Infections
  • ADHD
  • Wound Healing
  • Chronic Diarrhoea
  • Parkinson's Disease
  • Severe Protein Allergy
  • Pain Management
  • Other Cancer-Related Treatments
  • Orphan Diseases
  • Phenylketonuria
  • Eosinophilic esophagitis
  • Homocystinuria
  • Tyrosinemia
  • MSUD
  • FPIES
  • Constipation Relief
  • Epilepsy
  • Protein Booster
  • Dysphagia
  • Others

Medical Foods, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Medical Foods Market Insights

  • 4.1. Medical Foods Market - Application Snapshot
  • 4.2. Medical Foods Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Prevalence of Chronic Diseases
      • 4.2.1.2. Increased Health-Conscious Consumer Demand
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Limited Awareness and Access
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Medical Foods Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Medical Foods Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Medical Foods Market, by Product, 2019-2032 (USD Billion)
  • 5.3. Pills
    • 5.3.1. Global Medical Foods Market, by Pills, by Region, 2019-2032 (USD Billion)
  • 5.4. Powder
    • 5.4.1. Global Medical Foods Market, by Powder, by Region, 2019-2032 (USD Billion)
  • 5.5. Liquid
    • 5.5.1. Global Medical Foods Market, by Liquid, by Region, 2019-2032 (USD Billion)
  • 5.6. Others
    • 5.6.1. Global Medical Foods Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Medical Foods Market, by Route of Administration

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Medical Foods Market, by Route of Administration, 2019-2032 (USD Billion)
  • 6.3. Oral
    • 6.3.1. Global Medical Foods Market, by Oral, by Region, 2019-2032 (USD Billion)
  • 6.4. Enteral
    • 6.4.1. Global Medical Foods Market, by Enteral, by Region, 2019-2032 (USD Billion)

7. Global Medical Foods Market, by Application

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Medical Foods Market, by Application, 2019-2032 (USD Billion)
  • 7.3. Chronic Kidney Disease
    • 7.3.1. Global Medical Foods Market, by Chronic Kidney Disease, By Region, 2019-2032 (USD Billion)
  • 7.4. Minimal Hepatic Encephalopathy
    • 7.4.1. Global Medical Foods Market, by Minimal Hepatic Encephalopathy, By Region, 2019-2032 (USD Billion)
  • 7.5. Diabetic Neuropathy
    • 7.5.1. Global Medical Foods Market, by Diabetic Neuropathy, By Region, 2019-2032 (USD Billion)
  • 7.6. Depression
    • 7.6.1. Global Medical Foods Market, by Depression, By Region, 2019-2032 (USD Billion)
  • 7.7. Nutritional Deficiency
    • 7.7.1. Global Medical Foods Market, by Nutritional Deficiency, By Region, 2019-2032 (USD Billion)
  • 7.8. Chemotherapy Induced Diarrhoea
    • 7.8.1. Global Medical Foods Market, by Chemotherapy Induced Diarrhoea, By Region, 2019-2032 (USD Billion)
  • 7.9. Alzheimer's Disease
    • 7.9.1. Global Medical Foods Market, by Alzheimer's Disease, By Region, 2019-2032 (USD Billion)
  • 7.10. Pathogen Related Infections
    • 7.10.1. Global Medical Foods Market, by Pathogen Related Infections, By Region, 2019-2032 (USD Billion)
  • 7.11. ADHD
    • 7.11.1. Global Medical Foods Market, by ADHD, By Region, 2019-2032 (USD Billion)
  • 7.12. Wound Healing
    • 7.12.1. Global Medical Foods Market, by Wound Healing, By Region, 2019-2032 (USD Billion)
  • 7.13. Chronic Diarrhoea
    • 7.13.1. Global Medical Foods Market, by Chronic Diarrhoea, By Region, 2019-2032 (USD Billion)
  • 7.14. Parkinson's Disease
    • 7.14.1. Global Medical Foods Market, by Parkinson's Disease, By Region, 2019-2032 (USD Billion)
  • 7.15. Severe Protein Allergy
    • 7.15.1. Global Medical Foods Market, by Severe Protein Allergy, By Region, 2019-2032 (USD Billion)
  • 7.16. Pain Management
    • 7.16.1. Global Medical Foods Market, by Pain Management, By Region, 2019-2032 (USD Billion)
  • 7.17. Other Cancer-Related Treatments
    • 7.17.1. Global Medical Foods Market, by Other Cancer-Related Treatments, By Region, 2019-2032 (USD Billion)
  • 7.18. Orphan Diseases
    • 7.18.1. Global Medical Foods Market, by Orphan Diseases, By Region, 2019-2032 (USD Billion)
    • 7.18.2. Phenylketonuria
      • 7.18.2.1. Global Medical Foods Market, by Phenylketonuria, By Region, 2019-2032 (USD Billion)
    • 7.18.3. Eosinophilic esophagitis
      • 7.18.3.1. Global Medical Foods Market, by Eosinophilic esophagitis, By Region, 2019-2032 (USD Billion)
    • 7.18.4. Homocystinuria
      • 7.18.4.1. Global Medical Foods Market, by Homocystinuria, By Region, 2019-2032 (USD Billion)
    • 7.18.5. Tyrosinemia
      • 7.18.5.1. Global Medical Foods Market, by Tyrosinemia, By Region, 2019-2032 (USD Billion)
    • 7.18.6. MSUD
      • 7.18.6.1. Global Medical Foods Market, by MSUD, By Region, 2019-2032 (USD Billion)
    • 7.18.7. FPIES
      • 7.18.7.1. Global Medical Foods Market, by FPIES, By Region, 2019-2032 (USD Billion)
  • 7.19. Constipation Relief
    • 7.19.1. Global Medical Foods Market, by Constipation Relief, By Region, 2019-2032 (USD Billion)
  • 7.20. Epilepsy
    • 7.20.1. Global Medical Foods Market, by Epilepsy, By Region, 2019-2032 (USD Billion)
  • 7.21. Protein Booster
    • 7.21.1. Global Medical Foods Market, by Protein Booster, By Region, 2019-2032 (USD Billion)
  • 7.22. Dysphagia
    • 7.22.1. Global Medical Foods Market, by Dysphagia, By Region, 2019-2032 (USD Billion)
  • 7.23. Others
    • 7.23.1. Global Medical Foods Market, by Others, By Region, 2019-2032 (USD Billion)

8. Global Medical Foods Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Medical Foods Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Medical Foods Market - North America
    • 8.3.1. North America: Medical Foods Market, by Product, 2019-2032 (USD Billion)
    • 8.3.2. North America: Medical Foods Market, by Application, 2019-2032 (USD Billion)
    • 8.3.3. North America: Medical Foods Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.3.4. Medical Foods Market - U.S.
      • 8.3.4.1. U.S.: Medical Foods Market, by Product, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Medical Foods Market, by Application, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Medical Foods Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.3.5. Medical Foods Market - Canada
      • 8.3.5.1. Canada: Medical Foods Market, by Product, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Medical Foods Market, by Application, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Medical Foods Market, by Route of Administration, 2019-2032 (USD Billion)
  • 8.4. Medical Foods Market - Europe
    • 8.4.1. Europe: Medical Foods Market, by Product, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Medical Foods Market, by Application, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Medical Foods Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.4.4. Medical Foods Market - UK
      • 8.4.4.1. UK: Medical Foods Market, by Product, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Medical Foods Market, by Application, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Medical Foods Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.4.5. Medical Foods Market - France
      • 8.4.5.1. France: Medical Foods Market, by Product, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Medical Foods Market, by Application, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Medical Foods Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.4.6. Medical Foods Market - Germany
      • 8.4.6.1. Germany: Medical Foods Market, by Product, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Medical Foods Market, by Application, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Medical Foods Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.4.7. Medical Foods Market - Italy
      • 8.4.7.1. Italy: Medical Foods Market, by Product, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Medical Foods Market, by Application, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Medical Foods Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.4.8. Medical Foods Market - Spain
      • 8.4.8.1. Spain: Medical Foods Market, by Product, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Medical Foods Market, by Application, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Medical Foods Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.4.9. Medical Foods Market - Netherlands
      • 8.4.9.1. Netherlands: Medical Foods Market, by Product, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Medical Foods Market, by Application, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Medical Foods Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.4.10. Medical Foods Market - Russia
      • 8.4.10.1. Russia: Medical Foods Market, by Product, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Medical Foods Market, by Application, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Medical Foods Market, by Route of Administration, 2019-2032 (USD Billion)
  • 8.5. Medical Foods Market - Asia Pacific
    • 8.5.1. Asia Pacific: Medical Foods Market, by Product, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Medical Foods Market, by Application, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Medical Foods Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.5.4. Medical Foods Market - China
      • 8.5.4.1. China: Medical Foods Market, by Product, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Medical Foods Market, by Application, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Medical Foods Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.5.5. Medical Foods Market - India
      • 8.5.5.1. India: Medical Foods Market, by Product, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Medical Foods Market, by Application, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Medical Foods Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.5.6. Medical Foods Market - Malaysia
      • 8.5.6.1. Malaysia: Medical Foods Market, by Product, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Medical Foods Market, by Application, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Medical Foods Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.5.7. Medical Foods Market - Japan
      • 8.5.7.1. Japan: Medical Foods Market, by Product, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Medical Foods Market, by Application, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Medical Foods Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.5.8. Medical Foods Market - Indonesia
      • 8.5.8.1. Indonesia: Medical Foods Market, by Product, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Medical Foods Market, by Application, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Medical Foods Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.5.9. Medical Foods Market - South Korea
      • 8.5.9.1. South Korea: Medical Foods Market, by Product, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Medical Foods Market, by Application, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Medical Foods Market, by Route of Administration, 2019-2032 (USD Billion)
  • 8.6. Medical Foods Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Medical Foods Market, by Product, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Medical Foods Market, by Application, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Medical Foods Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.6.4. Medical Foods Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Medical Foods Market, by Product, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Medical Foods Market, by Application, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Medical Foods Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.6.5. Medical Foods Market - UAE
      • 8.6.5.1. UAE: Medical Foods Market, by Product, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Medical Foods Market, by Application, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Medical Foods Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.6.6. Medical Foods Market - Israel
      • 8.6.6.1. Israel: Medical Foods Market, by Product, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Medical Foods Market, by Application, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Medical Foods Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.6.7. Medical Foods Market - South Africa
      • 8.6.7.1. South Africa: Medical Foods Market, by Product, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Medical Foods Market, by Application, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Medical Foods Market, by Route of Administration, 2019-2032 (USD Billion)
  • 8.7. Medical Foods Market - Latin America
    • 8.7.1. Latin America: Medical Foods Market, by Product, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Medical Foods Market, by Application, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Medical Foods Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.7.4. Medical Foods Market - Mexico
      • 8.7.4.1. Mexico: Medical Foods Market, by Product, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Medical Foods Market, by Application, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Medical Foods Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.7.5. Medical Foods Market - Brazil
      • 8.7.5.1. Brazil: Medical Foods Market, by Product, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Medical Foods Market, by Application, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Medical Foods Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.7.6. Medical Foods Market - Argentina
      • 8.7.6.1. Argentina: Medical Foods Market, by Product, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Medical Foods Market, by Application, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Medical Foods Market, by Route of Administration, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Abbott
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Danone
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Fresenius Kabi
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Friso
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Mead Johnson & Company, LLC
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Medtrition, Inc.
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Morinaga Milk Industry
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Nestle S.A.
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Primus Pharmaceuticals, Inc.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Targeted Medical Pharma, Inc.
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦